Health Care & Life Sciences » Pharmaceuticals | Tianjin Tianyao Pharmaceutical Co. Ltd.

Tianjin Tianyao Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,474
1,379
1,399
1,669
1,945
2,397
Cost of Goods Sold (COGS) incl. D&A
1,282
1,181
1,181
1,200
1,251
1,227
Gross Income
192
198
217
469
694
1,171
SG&A Expense
112
109
132
325
480
865
EBIT
72
79
74
-
182
247
Unusual Expense
3
-
-
-
2
11
Non Operating Income/Expense
6
27
14
4
3
3
Interest Expense
27
27
18
-
11
24
Pretax Income
57
99
86
155
182
230
Income Tax
5
13
8
18
27
34
Equity in Affiliates
-
-
1
-
7
1
Consolidated Net Income
52
87
79
136
162
197
Net Income
52
87
79
98
130
153
Net Income After Extraordinaries
52
87
79
98
130
153
Net Income Available to Common
52
87
79
98
130
153
EPS (Basic)
0.05
0.09
0.08
0.10
0.12
0.14
Basic Shares Outstanding
961
961
961
961
1,091
1,092
EPS (Diluted)
0.05
0.09
0.08
0.10
0.12
0.14
Diluted Shares Outstanding
961
961
961
961
1,091
1,092
EBITDA
141
148
144
240
282
357
Other Operating Expense
-
7
10
11
32
58
Non-Operating Interest Income
-
8
15
13
16
11
Minority Interest Expense
-
-
-
39
33
44

About Tianjin Tianyao Pharmaceutical Co.

View Profile
Address
No.19, Xinye 9th Street
Tianjin Tianjin 300462
China
Employees -
Website http://www.kingyork.biz/tianyaoyaoye/
Updated 07/08/2019
Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the development, manufacture, distribution, and export of raw materials used for the manufacture of medicines, small capacity injections, and medicinal preparations. Its products include corticosteroids and cardiovascular medicine, dexamethasone, and cortisone acetate. The company was founded on December 1, 1999 and is headquartered in Tianjin, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.